Related Experiment Video
Updated: Jun 19, 2026
08:19
Hollow Microneedle-based Sensor for Multiplexed Transdermal Electrochemical Sensing
Published on: June 1, 2012
Microneedle-based automated therapy for diabetes mellitus
Puneet Khanna1, Joel A Strom, John I Malone
1Department of Electrical Engineering, University of South Florida, Tampa, Florida, USA.
Journal of Diabetes Science and Technology
|November 4, 2009
Summary
Microneedles offer a minimally invasive approach for advanced automated diabetes therapy systems. This bioengineered interface requires understanding skin
Area of Science:
- Biomedical Engineering
- Materials Science
- Endocrinology
Background:
- Current diabetes management involves invasive methods for glucose sensing and insulin delivery.
- Automated "closed-loop" systems promise improved glycemic control by integrating diagnostics and therapeutics.
- Microneedles present a novel, minimally invasive technology for transdermal delivery and sensing.
Purpose of the Study:
- To review the application-specific requirements for microneedle-based interfaces in autonomous diabetes therapy.
- To discuss key design considerations and interdependencies for developing such systems.
Main Methods:
- Review of existing literature on microneedle technology and diabetes management systems.
- Analysis of the human skin's properties as a biological barrier and interface.
- Discussion of multidisciplinary research needs for system development.
Main Results:
- Microneedles can facilitate noninvasive or minimally invasive transdermal transfer for diabetes therapy.
- Understanding skin's molecular architecture is crucial for effective microneedle design.
- Complex interdependencies necessitate a holistic, multidisciplinary approach to system development.
Conclusions:
- Microneedle technology is a promising interface for advanced, automated diabetes management systems.
- Further research into skin-microneedle interactions is essential for optimizing system performance.
- Integrated bioengineered systems require a comprehensive understanding of biological and physical factors.
More Related Videos
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:24Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...